Research and Markets: European Point of Care (POC) Infectious Disease Market - Multiple Benefits Support Widening Adoption of POCT

Research and Markets (http://www.researchandmarkets.com/research/e131ae/european_point_of) has announced the addition of Frost & Sullivan's new report "European Point of Care (POC) Infectious Disease Market" to their offering.

This research service gives a detailed analysis of the European point of care (POC) infectious disease market from 2008-2015.

Multiple Benefits Support Widening Adoption of POCT

Recent discoveries and innovations in the realm of molecular diagnostics hold the exciting promise of revolutionising the healthcare arena. "In particular, the evolution of POC testing is expected to have a significant impact on patient care management," notes the analyst of this research. "Additionally, public awareness initiatives and governmental campaigns across Europe are facilitating the uptake of new technologies and highlighting the value of POC molecular diagnostics in the improvement of medical care, reducing overall healthcare costs." One of the drivers associated with the growth of POC testing is the need for clinicians to quickly test results in settings where patient treatment decisions benefit from immediate diagnostic findings such as hospital emergency rooms and physician offices. "The market for POC diagnostic tests is growing rapidly," adds the analyst of this research. "Public health policy makers, insurers and governments are becoming more aware of the need to test for certain infectious diseases." Healthcare authorities such as the FDA, Centre for Disease Control (CDC) and WHO have recognised that certain rapid POC products are not only easier to use, reliable, sensitive and specific, but that they also can be more cost-effective than traditional diagnostic tests performed in the central laboratory.

Personnel Training Critical to Ensure Optimal Use of POCT

The primary concern articulated by most of the healthcare practitioners is the importance of ensuring the accuracy and reliability of POC test machines. In order to ensure accuracy, quality control is seen as important, including the training of personnel who routinely use the POC tests. The issue of cost is at the core of the POC tests and will ultimately dictate decisions regarding the implementation of the technology. The cost associated with staff performing extra duties could be a potential barrier; ensuring POC test quality is a resource-intensive endeavour that involves co-ordinating a variety of devices, locations and staff. The successful implementation and management of POC programmes in a hospital depends on the formation of a standing committee. This committee must be empowered by every level of administration to review all POC testing requests, to select instrumentation to be evaluated and to coordinate the oversight of existing and new POC testing programmes, all within the hospital budget.

"For POC devices, the principal technology challenges will continue to be in test chemistry," comments the analyst of the research. "This core science must facilitate laboratory quality test results while requiring minimal training for users as well as little or no calibration and maintenance." Today, user training becomes all the more important in order to meet the standards of laboratory testing. Hospitals should organise regular training programmes in collaboration with diagnostic device manufacturers to train staff that use the POC instrument regularly. At the same time, the successful establishment of a market for a new test would have marketing demands that are too high and timelines that are too long. Hence, the ideal option for diagnostic companies would be to partner with pharmaceutical firms and focus on those tests that have a clear link to specific therapies, in addition to having an immediate or prospective clinical potential.

Key Topics Covered:

1 Executive Summary

2 Glossary Of Terms And Exchange Rates

3 Industry Challenges

4 European Poc Infectious Disease Market

5 Market Engineering Strategic Recommendations

6 Database Of Key Industry Participants

7 Decision Support Databases

For more information visit http://www.researchandmarkets.com/research/e131ae/european_point_of

CONTACT: Laura Wood, Senior Manager, Research and Markets Fax: +1 646 607 1907 (US) Fax: +353 1 481 1716 (Rest of World) e-mail: press@researchandmarkets.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

Related terms: adoption, budget, clinical, disease, e-mail, emergency, engineering, europe, executive, healthcare, hospital, investment opinion, market, marketing, medical, pharmaceuticals, policy, products, quality control, research, science, technology, training, web